Cours Respirerx Pharmaceuticals Inc Other OTC
Actions
US2205243007
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
CA 2021 | - | CA 2022 | - | Capitalisation | 289 k 261 k |
---|---|---|---|---|---|
Résultat net 2021 | -3 M -2,71 M | Résultat net 2022 | -2 M -1,81 M | VE / CA 2021 | - |
Dette nette 2021 | 2,08 M 1,88 M | Dette nette 2022 | 2,71 M 2,45 M | VE / CA 2022 | - |
PER 2021 |
-0,29
x | PER 2022 |
-0,06
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 93,37% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/03/13 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/03/13 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15/10/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/03/13 |
Director/Board Member | - | 22/03/23 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/03/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+8,96% | 105 Md | |
-1,43% | 104 Md | |
+4,40% | 22,94 Md | |
-12,15% | 22,34 Md | |
-4,36% | 19,25 Md | |
-39,98% | 17,08 Md | |
-10,04% | 16,96 Md | |
+38,61% | 12,63 Md | |
+313,59% | 8,49 Md |
- Bourse
- Actions
- Action RSPI
- Action